mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein.

Guglielmelli, Tommasina; Giugliano, Emilia; Brunetto, Vanessa; Rapa, Ida; Cappia, Susanna; Giorcelli, Jessica; Rrodhe, Sokol; Papotti, Mauro; Saglio, Giuseppe

Guglielmelli, Tommasina; Giugliano, Emilia; Brunetto, Vanessa; Rapa, Ida; Cappia, Susanna; Giorcelli, Jessica; Rrodhe, Sokol; Papotti, Mauro; Saglio, Giuseppe.

Afiliación

Guglielmelli T; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Giugliano E; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Brunetto V; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Rapa I; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Cappia S; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Giorcelli J; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Rrodhe S; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Papotti M; Department of Oncology, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.
Saglio G; Department of Clinical and Biological Sciences, University of Turin and S Luigi Hospital, Orbassano, Turin, Italy.

Oncoscience ; 2(4): 382-94, 2015.

Article en En | MEDLINE | ID: mdl-26097872

Palabras clave

AKT; mTOR pathway; multiple myeloma; nuclear; pomalidomide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoscience Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google